Ovarian Cancer Immunotherapy includes cancer vaccines, adoptive T-cell therapy and immunomodulatory agents. Immunotherapy enhances efficiency of cancer vaccines and antitumor immune response.
Future research focuses on the synergistic immunotherapy combinations for effective and safe approach. The most significant risk factor for ovarian cancer is a strong family history of breast or ovarian cancer.
Related Journals of Ovarian Cancer Immunotherapy
Immunotherapy: Open Access, Immunooncology journal, Immunobiology journal, Immunology Journal, Immunome Research journal, Journal of Immunology Research, Journal of Immunotherapy of Cancer, Journal of Hematology & Oncology, Annals of Oncology, Human Vaccines & Immunotherapeutics.
